Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Basal Cell 3Margins of Excision 2Barrett Esophagus 2Urologic Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Prostatic Neoplasms 1Pancreatic Cyst 1Nevus, Pigmented 1Nephrolithiasis 1Multicystic renal dysplasia, bilateral 1Melanoma 1Lung Neoplasms 1Lung Diseases 1Hematuria 1Esophageal Neoplasms 1Benign Neoplasm of Liver and/or Biliary Ducts 1Adenocarcinoma 1

Interventions

Carboplatin 19Pemetrexed 10Paclitaxel 7pembrolizumab 5Nivolumab 5Cisplatin 5Gemcitabine 4osimertinib 3entinostat 3camrelizumab 3atezolizumab 3Erlotinib Hydrochloride 3zipalertinib 2selpercatinib 2pralsetinib 2durvalumab 2apatinib 2Vinorelbine 2Surveys and Questionnaires 2One-Lung Ventilation 2Ipilimumab 2Docetaxel 2Bevacizumab 2130-nm albumin-bound paclitaxel 2zimberelimab 1toripalimab 1spartalizumab 1sotorasib 1sitravatinib 1sintilimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Lung Diseases × Microscopy, Confocal × Clear all
NCT00934778 2016-11-28

Minimally Invasive Endoscopy in Diffuse Lung Disease

Royal Brompton & Harefield NHS Foundation Trust

Phase NA Completed
100 enrolled
Thoracic

Lung Diseases, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡